Activation of the Pro-survival Phosphatidylinositol 3-Kinase/AKT Pathway by Transforming Growth Factor-β1 in Mesenchymal Cells Is Mediated by p38 MAPK-dependent Induction of an Autocrine Growth Factor
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
Transforming growth factor-beta1 (TGF-beta1) is a multifunctional cytokine involved in differentiation, growth, and survival of mesenchymal cells while inhibiting growth/survival of most other cell types. The mechanism(s) of pro-survival signaling by TGF-beta1 in mesenchymal cells is unclear. In this report, we demonstrate that TGF-beta1 protects against serum deprivation-induced apoptosis of mesenchymal cells isolated from patients with acute lung injury and of normal human fetal lung fibroblasts (IMR-90). TGF-beta receptor(s)-activated signaling in these cells involves rapid activation of the Smad and p38 MAPK pathways within minutes of TGF-beta1 treatment followed by a more delayed activation of the pro-survival phosphatidylinositol 3-kinase-protein kinase B (PKB)/Akt pathway. Pharmacological inhibition of p38 MAPK with SB203580 or expression of a p38 kinase-deficient mutant protein inhibits TGF-beta1-induced PKB/Akt phosphorylation. Conditioned medium from TGF-beta1-treated cells rapidly induces PKB/Akt activation in an SB203580- and suramin-sensitive manner, suggesting p38 MAPK-dependent production of a secreted growth factor that activates this pro-survival pathway by an autocrine/paracrine mechanism. Inhibition of the phosphatidylinositol 3-kinase-PKB/Akt pathway blocks TGF-beta1-induced resistance to apoptosis. These results demonstrate the activation of a novel TGF-beta1-activated pro-survival/anti-apoptotic signaling pathway in mesenchymal cells/fibroblasts that may explain cell-specific actions of TGF-beta1 and provide mechanistic insights into its pro-fibrotic and tumor-promoting effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The use of p38 MAPK inhibitors also lowers TGFβ-induced collagen type I and αSMA production and prevents TGFβ-induced AKT signaling (53–55).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [55]
Citations
Cites
The Acute Respiratory Distress Syndrome
Matthay, M. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342209 · Cited by 4,923
The Acute Respiratory Distress Syndrome
Ware, L. B., & Matthay, M. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421806 · Cited by 4,666
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V, & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,866
Ignotz, R. A., & Massagué, J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35666-1 · Cited by 2,492
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
Research works printed but not linked: 3
- Desmouliere, 1995, Am. J. Pathol., 146, 56
- Janin, 1990, Clin. Exp. Rheumatol., 8, 237
- Valdes, 2002, Mol. Cancer Res., 1, 68
Cited by
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
Self-citationRecent Developments in Myofibroblast Biology
Hinz, B., Phan, S. H., Thannickal, V. J., Prunotto, M., Desmoulière, A., Varga, J., De Wever, O., Mareel, M., & Gabbiani, G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.004 · Cited by 1,193
“The mechanisms that produce an apoptosis-resistant myofibroblast phenotype have not been fully elucidated, although some of the same factors that mediate myofibroblast differentiation appear to promote myofibroblast survival.(90,127,128) A member of the NOX family of enzymes, NOX4 has been required for TGF 1-induced m…”
BackgroundSelf-citationSignaling cross-talk between TGF-β/BMP and other pathways
Guo, X., & Wang, X.-F. (2009) · Cell Research · doi:10.1038/cr.2008.302 · Cited by 1,015
NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury
Hecker, L., Vittal, R., Jones, T., Jagirdar, R., Luckhardt, T. R., Horowitz, J. C., Pennathur, S., Martinez, F. J., & Thannickal, V. J. (2009) · Nature Medicine · doi:10.1038/nm.2005 · Cited by 852
Self-citationSignaling Cross Talk between TGF-β/Smad and Other Signaling Pathways
Luo, K. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022137 · Cited by 639
Host Responses in Tissue Repair and Fibrosis
Duffield, J. S., Lupher, M., Thannickal, V. J., & Wynn, T. A. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163930 · Cited by 624
Self-citationEvasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Hinz, B., & Lagares, D. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0324-5 · Cited by 614
Metformin reverses established lung fibrosis in a bleomycin model
Rangarajan, S., Bone, N. B., Zmijewska, A. A., Jiang, S., Park, D. W., Bernard, K., Locy, M. L., Ravi, S., Deshane, J., Mannon, R. B., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0087-6 · Cited by 560
Self-citationIdiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
Vancheri, C., Failla, M., Crimi, N., & Raghu, G. (2010) · European Respiratory Journal · doi:10.1183/09031936.00077309 · Cited by 464
Evolving Concepts of Apoptosis in Idiopathic Pulmonary Fibrosis
Thannickal, V. J., & Horowitz, J. C. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-001tk · Cited by 364
“In this context, the acquisition of an apoptosis-resistant phenotype of myofibroblasts induced by TGF- 1 is, at least in part, due to the autocrine secretion of a soluble growth factor that activates the PI3K–Akt pathway (46).”
BackgroundSelf-citationBafna, S., Kaur, S., & Batra, S. K. (2010) · Oncogene · doi:10.1038/onc.2010.87 · Cited by 360
“Growth factor-induced activation of Akt via p38 has previously been shown as a pro-survival pathway in lung cells (Horowitz et al., 2004).”
Myofibroblasts: Trust your heart and let fate decide
Davis, J., & Molkentin, J. D. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.10.019 · Cited by 345
“Fibroblasts treated with TGFβ are resistant to apoptotic cell death initiated by Fas ligand (TNFα pathway) [37,38], interleukin-1 (IL-1) [39], and serum starvation [40,41].”
Backgroundp38 MAP kinase: a convergence point in cancer therapy
Olson, J. M., & Hallahan, A. R. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.01.007 · Cited by 335
The role of myofibroblasts in wound healing
Hinz, B. (2016) · Current Research in Translational Medicine · doi:10.1016/j.retram.2016.09.003 · Cited by 328
“in turn, prevents myofibroblast apoptosis induced by serum deprivation [151,152].”
BackgroundIdiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
Ballester, B., Milara, J., & Cortijo, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030593 · Cited by 308
“In fact, overexpression of class I isoform p110γ in lung homogenates occurs in IPF patients [173], and has been shown to activate the downstream signalling of several key profibrotic growth factors implicated in IPF, including PDGF and TGFβ1 [174,175], as well as abnormal proliferation of epithelial basal cells [173]…”
InfluentialGastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation
Qu, J.-L., Qu, X.-J., Zhao, M.-F., Teng, Y.-E., Zhang, Y., Hou, K.-Z., Jiang, Y.-H., Yang, X.-H., & Liu, Y.-P. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.04.006 · Cited by 304
Extracellular matrix in lung development, homeostasis and disease
Zhou, Y., Horowitz, J. C., Naba, A., Ambalavanan, N., Atabai, K., Balestrini, J., Bitterman, P. B., Corley, R. A., Ding, B.-S., Engler, A. J., et al. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.005 · Cited by 284
Self-citationFibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
Sakai, & Tager, A. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.001 · Cited by 285
“In lung fibroblasts, TGF-β induction of αSMA and collagen expression has been shown to be dependent on ERK and p38 MAPK [56–57], and p38 MAPK activation by TGF-β has been shown to contributes to fibroblast resistance to apoptosis through the pro-survival phosphatidyl inositol 3-kinase (PI3K)/AKT pathway [58].”
Waghray, M., Cui, Z., Horowitz, J. C., Subramanian, I. M., Martinez, F. J., Toews, G. B., & Thannickal, V. J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2882fje · Cited by 270
“Cultured fibroblasts that actively generate ROS do not, in general, appear to be under increased “stress,” and in fact, are resistant to serum deprivation-induced apoptosis (12, 13).”
BackgroundSelf-citationThe regulatory role of TGF‐β in airway remodeling in asthma
Makinde, T., Murphy, R. F., & Agrawal, D. K. (2007) · Immunology & Cell Biology · doi:10.1038/sj.icb.7100044 · Cited by 265
Targeting the transforming growth factor-β signaling pathway in human cancer
Nagaraj, N. S., & Datta, P. K. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903382609 · Cited by 262
“This protection from cell death is blocked by the PI3 kinase inhibitor LY-294002 [100] or TGF-bRI kinase inhibitors [101].”
BackgroundVan De Water, L., Varney, S., & Tomasek, J. J. (2013) · Advances in Wound Care · doi:10.1089/wound.2012.0393 · Cited by 251
Horowitz, J. C., Rogers, D. S., Sharma, V., Vittal, R., White, E. S., Cui, Z., & Thannickal, V. J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.10.001 · Cited by 242
Self-citationMetabolic Reprogramming Is Required for Myofibroblast Contractility and Differentiation
Bernard, K., Logsdon, N. J., Ravi, S., Xie, N., Persons, B. P., Rangarajan, S., Zmijewski, J. W., Mitra, K., Liu, G., Darley-Usmar, V. M., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.646984 · Cited by 224
“We have previously demonstrated the early activation of p38 MAPK in response to TGF-β1 in IMR-90 fibroblasts (52).”
BackgroundSelf-citationChin, B. Y., Jiang, G., Wegiel, B., Wang, H. J., MacDonald, T., Zhang, X. C., Gallo, D., Cszimadia, E., Bach, F. H., Lee, P. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609611104 · Cited by 225
Type I Transforming Growth Factor β Receptor Binds to and Activates Phosphatidylinositol 3-Kinase
Yi, J. Y., Shin, I., & Arteaga, C. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413223200 · Cited by 228
Myofibroblast differentiation and survival in fibrotic disease
Kis, K., Liu, X., & Hagood, J. S. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001967 · Cited by 224
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis
Woodcock, H. V., Eley, J. D., Guillotin, D., Platé, M., Nanthakumar, C. B., Martufi, M., Peace, S., Joberty, G., Poeckel, D., Good, R. B., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07858-8 · Cited by 224
Wilkes, M. C., Mitchell, H., Penheiter, S. G., Doré, J. J., Suzuki, K., Edens, M., Sharma, D. K., Pagano, R. E., & Leof, E. B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1522 · Cited by 216
Signaling Pathways Involved in Diabetic Renal Fibrosis
Zhang, Y., Jin, D., Kang, X., Zhou, R., Sun, Y., Lian, F., & Tong, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.696542 · Cited by 210
“Some researchers hold the view that TGF-β directly activates PI3K and subsequently stimulates Akt production (Higaki and Shimokado, 1999), while others consider TGF-β-induced activation of PI3K as p38MAPK dependent (Horowitz et al., 2004).”
BackgroundExploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
Mercer, P. F., Woodcock, H. V., Eley, J. D., Platé, M., Sulikowski, M. G., Durrenberger, P. F., Franklin, L., Nanthakumar, C. B., Man, Y., Genovese, F., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207429 · Cited by 206
Diminished Prostaglandin E 2 Contributes to the Apoptosis Paradox in Idiopathic Pulmonary Fibrosis
Maher, T. M., Evans, I. C., Bottoms, S. E., Mercer, P. F., Thorley, A. J., Nicholson, A. G., Laurent, G. J., Tetley, T. D., Chambers, R. C., & McAnulty, R. J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0674oc · Cited by 196
Dhanisha, S. S., Guruvayoorappan, C., Drishya, S., & Abeesh, P. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.12.006 · Cited by 194
Kulkarni, A. A., Thatcher, T. H., Olsen, K. C., Maggirwar, S. B., Phipps, R. P., & Sime, P. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015909 · Cited by 189
“. Multiple upstream signaling events can activate Akt via PI3K. In fetal lung fibroblasts”
BackgroundBernard, K., Logsdon, N. J., Benavides, G. A., Sanders, Y., Zhang, J., Darley-Usmar, V. M., & Thannickal, V. J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000444 · Cited by 174
“2 also been shown to participate in myofibroblast differentiation (6-8).”
Self-citationIsmail, S., Sturrock, A., Wu, P., Cahill, B., Norman, K., Huecksteadt, T., Sanders, K., Kennedy, T., & Hoidal, J. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90488.2008 · Cited by 177
“TGF- 1 also signals through the PI3K/Akt pathway (24).”
BackgroundCCL5 increases lung cancer migration via PI3K, Akt and NF-κB pathways
Huang, C.-Y., Fong, Y.-C., Lee, C.-Y., Chen, M.-Y., Tsai, H.-C., Hsu, H.-C., & Tang, C.-H. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.014 · Cited by 176
Rodríguez‐García, A., Samsó, P., Fontova, P., Simon‐Molas, H., Manzano, A., Castaño, E., Rosa, J. L., Martinez‐Outshoorn, U., Ventura, F., Navarro‐Sabaté, À., et al. (2017) · The FEBS Journal · doi:10.1111/febs.14201 · Cited by 174
Lash, G. E., Otun, H. A., Innes, B. A., Bulmer, J. N., Searle, R. F., & Robson, S. C. (2005) · Biology of Reproduction · doi:10.1095/biolreprod.105.040337 · Cited by 171
“While this observation needs confirmation, it is interesting to note that TGFB-mediated apoptosis is known to be context dependent; in mesenchymal cells, TGFB1 has recently been shown to activate the prosurvival phospatidylinositol 3-kinase/AKT pathway [24].”
BackgroundWang, S. E., Xiang, B., Guix, M., Olivares, M. G., Parker, J., Chung, C. H., Pandiella, A., & Arteaga, C. L. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00787-08 · Cited by 165
Sisson, T. H., Ajayi, I. O., Subbotina, N., Dodi, A. E., Rodansky, E. S., Chibucos, L. N., Kim, K. K., Keshamouni, V. G., White, E. S., Zhou, Y., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.12.005 · Cited by 158
Self-citationKulasekaran, P., Scavone, C. A., Rogers, D. S., Arenberg, D. A., Thannickal, V. J., & Horowitz, J. C. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0447oc · Cited by 156
Self-citationUnraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
Myostatin Regulates Cardiomyocyte Growth Through Modulation of Akt Signaling
Morissette, M. R., Cook, S. A., Foo, S., McKoy, G., Ashida, N., Novikov, M., Scherrer-Crosbie, M., Li, L., Matsui, T., Brooks, G., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000231290.45676.d4 · Cited by 153
Reversible differentiation of myofibroblasts by MyoD
Hecker, L., Jagirdar, R., Jin, T., & Thannickal, V. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.03.016 · Cited by 153
“Weprepared cell lysates in RIPA buffer, subjected them to SDS-PAGE under reducing conditions and performed western immunoblotting as previously described [12].”
MethodSelf-citationProstaglandin E 2 induces fibroblast apoptosis by modulating multiple survival pathways
Huang, S. K., White, E. S., Wettlaufer, S. H., Grifka, H., Hogaboam, C. M., Thannickal, V. J., Horowitz, J. C., & Peters-Golden, M. (2009) · The FASEB Journal · doi:10.1096/fj.08-128801 · Cited by 147
“We measured ssDNA by immunoassay, as described previously (32).”
MethodSelf-citationEpithelial-Mesenchymal Interactions in Pulmonary Fibrosis
Horowitz, J., & Thannickal, V. (2006) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2006-957332 · Cited by 146
“Additionally, the profibrotic mediator, TGF-b1, confers fibroblast resistance apoptosis induced by serum-deprivation and interleukin-1b.(87,88) Contextual signals transmitted from the ECM may be important in the regulation of myofibroblast survival/ apoptosis.”
BackgroundSelf-citationActivation of p38 Has Opposing Effects on the Proliferation and Migration of Endothelial Cells
McMullen, M. E., Bryant, P. W., Glembotski, C. C., Vincent, P. A., & Pumiglia, K. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407060200 · Cited by 160
Muraoka-Cook, R. S., Shin, I., Yi, J. Y., Easterly, E., Barcellos‐Hoff, M. H., Yingling, J. M., Zent, R., & Arteaga, C. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208964 · Cited by 139
“TGFb-mediated cell motility and protection from apoptosis are blocked by LY294002 and/or expression of dominant-negative Akt (Bakin et al., 2000; Shin et al., 2001; Horowitz et al., 2004; Muraoka-Cook et al., 2004).”
BackgroundOjiaku, C. A., Yoo, E., & Panettieri, R. A. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0307tr · Cited by 153
TGF-β1 Protects against Mesangial Cell Apoptosis via Induction of Autophagy
Ding, Y., Kim, J. K., Kim, S. I., Na, H.-J., Jun, S. Y., Lee, S. J., & Choi, M. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.093724 · Cited by 130
Kattla, J. J., Carew, R. M., Heljić, M., Godson, C., & Brazil, D. P. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00548.2007 · Cited by 130
“In contrast, Horowitz and colleagues observed that TGFβ-mediated PKB/Akt activation is p38MAPK dependent in fetal lung fibroblasts (18).”
BackgroundMechanisms for the Resolution of Organ Fibrosis
Horowitz, J. C., & Thannickal, V. J. (2018) · Physiology · doi:10.1152/physiol.00033.2018 · Cited by 144
Self-citationVittal, R., Horowitz, J. C., Moore, B. B., Zhang, H., Martínez, F. J., Toews, G. B., Standiford, T. J., & Thannickal, V. J. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62260-2 · Cited by 129
“Recent studies from our laboratory demonstrate that TGF- 1 promotes this prosurvival/antiapoptotic phenotype by p38 MAPK-dependent induction of a secreted growth factor(s) that activates the PI3KPKB/Akt pathway in an autocrine manner.(22) The PI3K-PKB/Akt pathway is known to regulate a number of cellular processes inc…”
BackgroundSelf-citationIPF: new insight on pathogenesis and treatment
Harari, S., & Caminati, A. (2010) · Allergy · doi:10.1111/j.1398-9995.2009.02305.x · Cited by 118
Myofibroblasts and lung fibrosis induced by carbon nanotube exposure
Dong, J., & Ma, Q. (2016) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0172-2 · Cited by 119
Chang, W., Wei, K., Jacobs, S. S., Upadhyay, D., Weill, D., & Rosen, G. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025684 · Cited by 113
Cardiomyocyte ATP release through pannexin 1 aids in early fibroblast activation
Dolmatova, E. V., Spagnol, G., Boassa, D., Baum, J. R., Keith, K., Ambrosi, C., Kontaridis, M. I., Sorgen, P. L., Sosinsky, G. E., & Duffy, H. S. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00251.2012 · Cited by 126
RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase
Imamura, M., Moon, J., Chung, K., Nakahira, K., Muthukumar, T., Shingarev, R. A., Ryter, S. W., Choi, A. M. K., & Choi, M. E. (2018) · JCI Insight · doi:10.1172/jci.insight.94979 · Cited by 114
“TGF-β1 can activate the serine/threonine kinase AKT by inducing its phosphorylation in fibroblasts (10).”
BackgroundWang, S. E., Shin, I., Wu, F. Y., Friedman, D. B., & Arteaga, C. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2071 · Cited by 107
Inhibition of TGFβ signaling in cancer therapy
Arteaga, C. L. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.12.009 · Cited by 125
Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
Hu, M., Che, P., Han, X., Cai, G., Liu, G., Antony, V. B., Luckhardt, T., Siegal, G. P., Zhou, Y., Liu, R.-M., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.216044 · Cited by 113
“We speculate that the delayed activation of Src may be mediated by autocrine secretion of growth factors that have been shown to activate the phosphatidylinositide 3-kinase–Akt pathway in a delayed manner after TGF-b stimulation (Horowitz et al., 2004).”
BackgroundSelf-citationAkt2 Phosphorylates Ezrin to Trigger NHE3 Translocation and Activation
Shiue, H., Musch, M. W., Wang, Y., Chang, E. B., & Turner, J. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409471200 · Cited by 104
Hepatocyte growth factor in lung repair and pulmonary fibrosis
Panganiban, R. A. M., & Day, R. M. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.90 · Cited by 117
Murillo, M. M., Carmona‐Cuenca, I., del Castillo, G., Ortiz, C., Roncero, C., Sánchez, A., Fernández, M., & Fabregat, I. (2007) · Biochemical Journal · doi:10.1042/bj20061846 · Cited by 107
Thomas, P. E., Peters-Golden, M. L., White, E. S., Thannickal, V. J., & Moore, B. B. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00489.2006 · Cited by 100
“In fact, our previous studies (15) have suggested inhibition of the Akt pathway induces apoptosis in TGF- 1-treated IMR-90 cells only after 5 days.”
BackgroundInfluentialSelf-citationPechkovsky, D. V., Scaffidi, A. K., Hackett, T. L., Ballard, J., Shaheen, F., Thompson, P. J., Thannickal, V. J., & Knight, D. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708226200 · Cited by 99
Self-citationPlasminogen Activation–Induced Pericellular Fibronectin Proteolysis Promotes Fibroblast Apoptosis
Horowitz, J. C., Rogers, D. S., Simon, R. H., Sisson, T. H., & Thannickal, V. J. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0174oc · Cited by 99
“Normal primary human embryonic lung fibroblasts (IMR-90 [26]; Institute for Medical Research, Camden, NJ) were cultured as previously described (9) and studies performed at passages 5 to 9.”
BackgroundMethodInfluentialSelf-citationEhata, S., Hanyu, A., Hayashi, M., Aburatani, H., Kato, Y., Fujime, M., Saitoh, M., Miyazawa, K., Imamura, T., & Miyazono, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1522 · Cited by 94
The cytokines of pulmonary fibrosis: Much learned, much more to learn
Luzina, I. G., Todd, N. W., Sundararajan, S., & Atamas, S. P. (2014) · Cytokine · doi:10.1016/j.cyto.2014.11.008 · Cited by 100
Cross-talk between IGF-I and TGF-β signaling pathways
Danielpour, D., & SONG, K. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.007 · Cited by 96
The aged extracellular matrix and the profibrotic role of senescence-associated secretory phenotype
Mebratu, Y. A., Soni, S., Rosas, L., Rojas, M. M., Horowitz, J. C., & Nho, R. S. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00124.2023 · Cited by 103
Self-citationHDAC-mediated control of ERK- and PI3K-dependent TGF-β-induced extracellular matrix-regulating genes
Barter, M. J., Pybus, L. P., Litherland, G. J., Rowan, A. D., Clark, I. M., Edwards, D. R., Cawston, T. E., & Young, D. A. (2010) · Matrix Biology · doi:10.1016/j.matbio.2010.05.002 · Cited by 102
Biomechanical Force and Cellular Stiffness in Lung Fibrosis
Nho, R. S., Ballinger, M. N., Rojas, M. M., Ghadiali, S. N., & Horowitz, J. C. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.02.001 · Cited by 94
“Moreover, 320 TGF-β, AKT/mTOR and NF-kB-dependent pathways that are associated with lung fibrosis are 321 known to regulate LOX genes.(27,28,70) While the role of LOX enzymes in cross-linking and 322 stiffness of collagen-rich tissues seems clear and their contribution to fibrogenesis is plausible, a 323 recent clinic…”
BackgroundSelf-citationTGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells
Suwanabol, P. A., Seedial, S. M., Zhang, F., Shi, X., Si, Y., Liu, B., & Kent, K. C. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00966.2011 · Cited by 85
Kurundkar, A., Kurundkar, D., Rangarajan, S., Locy, M. L., Zhou, Y., Liu, R.-M., Zmijewski, J. W., & Thannickal, V. J. (2016) · The FASEB Journal · doi:10.1096/fj.201500173 · Cited by 87
Self-citationdel Castillo, G., Murillo, M. M., Alvarez, A. M., Bertrán, E., Fernández, M., Sánchez, A., & Fabregat, I. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.05.017 · Cited by 93
Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis
Horowitz, J. C., Ajayi, I. O., Kulasekaran, P., Rogers, D. S., White, J. B., Townsend, S. K., White, E. S., Nho, R. S., Higgins, P. D. R., Huang, S. K., et al. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.011 · Cited by 78
“…TGF-β1 are strongly associated with fibrogenesis through stimulation of myofibroblast differentiation, ECM synthesis, and resistance to apoptosis (Horowitz et al., 2004, Horowitz et al., 2007, Kulasekaran et al., 2009, Thannickal et al., 2003, Shi-Wen et al., 2004, Shi-wen et al., 2007a,…”
BackgroundSelf-citationKapoun, A. M., Gaspar, N. J., Wang, Y., Damm, D., Liu, Y.-W., O’Young, G., Quon, D. H., Lam, A., Munson, K., Tran, T.-T., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021600 · Cited by 77
X-Linked Inhibitor of Apoptosis Regulates Lung Fibroblast Resistance to Fas-Mediated Apoptosis
Ajayi, I. O., Sisson, T. H., Higgins, P., Booth, A. J., Sagana, R. L., Huang, S. K., White, E. S., King, J. E., Moore, B. B., & Horowitz, J. C. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0224oc · Cited by 81
“We next determined whether TGF-b1 and ET-1, soluble mediators mechanistically implicated in fibrogenesis and fibroblast resistance to apoptosis, could increase XIAP expression levels in normal lung fibroblasts (7, 9, 11, 43).”
Self-citationPathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis
Antoniou, K. M., Pataka, A., Bouros, D. E., & Siafakas, N. M. (2006) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2006.01.002 · Cited by 76
Yeh, Y.-Y., Chiao, C.-C., Kuo, W.-Y., Hsiao, Y., Chen, Y., Wei, Y., Lai, T.-H., Fong, Y., & Tang, C. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.11.017 · Cited by 77
Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective
Gerarduzzi, C., & Battista, J. A. D. (2016) · Inflammation Research · doi:10.1007/s00011-016-1019-x · Cited by 76
Biswas, S., Criswell, T. L., Wang, S. E., & Arteaga, C. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0952 · Cited by 77
Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis
Barnes, J. W., Duncan, D., Helton, S., Hutcheson, S. B., Kurundkar, D., Logsdon, N. J., Locy, M. L., Garth, J. M., Denson, R. S., Farver, C. F., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00246.2018 · Cited by 71
Self-citationKim, H. J., Oh, J. E., Kim, S. W., Chun, Y. J., & Kim, M. Y. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.10.030 · Cited by 72
Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts
Sisson, T. H., Maher, T. M., Ajayi, I. O., King, J. E., Higgins, P., Booth, A. J., Sagana, R. L., Huang, S. K., White, E. S., Moore, B. B., et al. (2012) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2012.326085 · Cited by 70
“Accumulating studies also show that fibrotic lung fibroblasts are resistant to a variety of apoptotic stimuli, further supporting a role for impaired fibroblast apoptosis in the pathobiology of IPF [18-25].”
BackgroundSelf-citationBanh, A., Deschamps, P. A., Gauldie, J., Overbeek, P. A., Sivak, J. G., & West‐Mays, J. A. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1208 · Cited by 66
Wang, Y., Chen, S., Yan, Z., & Pei, M. (2019) · Cell & Bioscience · doi:10.1186/s13578-018-0264-9 · Cited by 56
Lin, C.-C., Chiang, L.-L., Lin, C., Shih, C.-H., Liao, Y., Hsu, M., & Chen, B.-C. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.025 · Cited by 67
DNA methylation regulated gene expression in organ fibrosis
Zhang, X., Hu, M., Lyu, X., Li, C., Thannickal, V. J., & Sanders, Y. Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.05.010 · Cited by 75
Self-citationInvolvement of matrix metalloproteinase-3 in CCL5/CCR5 pathway of chondrosarcomas metastasis
Tang, C., Yamamoto, A., Lin, Y., Fong, Y., & Tan, T. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.006 · Cited by 61
Palau, V. E., Pino, V., Farooq, A., Carraway, C. A. C., Salas, P. J. I., & Carraway, K. L. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-09-0895 · Cited by 64
“Interestingly, phosphorylation of p38 activates Akt at serine 473, and not at threonine 308, which is associated with cell survival (Horowitz et al., 2004).”
Vittal, R., Zhang, H., Han, M. K., Moore, B. B., Horowitz, J. C., & Thannickal, V. J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.113407 · Cited by 59
Self-citationBiological approaches for hypertrophic scars
Lingzhi, Z., Li, M., & Fu, X. (2019) · International Wound Journal · doi:10.1111/iwj.13286 · Cited by 62
“As aspect to be insensitive to apoptotic signalling and expressing antiapoptoticrelated molecules in myofibroblasts,(117) two kinases have been suggested to control myofibroblasts apoptosis, including phosphatidylinositol 3-kinase (PI3K)-AKT and focal adhesion kinase signalling.(118,119) Small molecule inhibitors targ…”
BackgroundBurgess, J. K. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.12.002 · Cited by 67
“…proliferation of fibroblasts and proliferation and survival of ASM cells, although conflicting data indicating that TGFβ inhibits proliferation of mesenchymal cells has also been reported (Raghu et al., 1988; Zhang & Phan, 1999; Chen & Khalil, 2002; Horowitz et al., 2004; Chen & Khalil, 2006).”
BackgroundHorowitz, J. C., Cui, Z., Moore, T. A., Meier, T. R., Reddy, R. C., Toews, G. B., Standiford, T. J., & Thannickal, V. J. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00276.2005 · Cited by 58
“Our previous studies demonstrated that TGF- 1 induces activation of the PI3K-PKB/Akt pathway in human lung fibroblasts by a p38 MAPK-dependent mechanism (32).”
BackgroundMethodInfluentialSelf-citationFong, Y., Hsu, S.-F., Wu, C.-L., Li, T., Kao, S.-T., Tsai, F., Chen, W., Liu, S., Wu, C.-M., & Tang, C. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.07.010 · Cited by 59
Pelaia, G., Gallelli, L., D’Agostino, B., Vatrella, A., Cuda, G., Fratto, D., Renda, T., Galderisi, U., Piegari, E., Crimi, N., et al. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20884 · Cited by 57
“Moreover, p38 activation by TGF-b1 leads to the production of an autocrine growth factor which is responsible for prolonged survival of lung fibroblasts (Horowitz et al., 2004).”
BackgroundГордеева, О. Ф. (2019) · Cells · doi:10.3390/cells8121500 · Cited by 60
Metadata
- Authors
- Horowitz, J. C., Lee, D. Y., Waghray, M., Keshamouni, V. G., Thomas, P. E., Zhang, H., Cui, Z., & Thannickal, V. J.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Thannickal, Victor J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 279
- Issue
- 2
- Pages
- 1359-1367
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC1360222
- OpenAlex
- W1965916788
- Cited by
- 239
- References
- 55
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 3 · 2021: 9 · 2020: 2 · 2019: 13 · 2018: 13 · 2017: 9 · 2016: 15 · 2015: 9 · 2014: 10 · 2013: 12 · 2012: 14
- FWCI
- 6.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6145 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P50HL074024, R01-HL-67967, R01HL067967, P50 HL-74021)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- TGF-β1, PI3K/Akt signaling, p38 MAPK, mesenchymal cells, lung fibroblasts, apoptosis resistance, autocrine growth factor, Smad signaling, acute lung injury, pulmonary fibrosis
- MeSH terms
- Cell Division, Cell Survival, Cells, Cultured, Densitometry, DNA, Single-Stranded, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Enzyme-Linked Immunosorbent Assay, Fibroblasts, Growth Substances, Humans, Imidazoles, Lung, Mesoderm, Microscopy, Fluorescence, Models, Biological, Mutation, Phenotype, Phosphorylation, Plasmids, Pyridines, Time Factors, Blotting, Western, Signal Transduction, Cytokines, Transforming Growth Factor beta, Culture Media, Conditioned, Apoptosis, Phosphatidylinositol 3-Kinases, Caspases, Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Caspase 3, Transforming Growth Factor beta1, Transforming Growth Factor beta2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.